Anti-aging Medical Products Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Halo™ – Hybrid Fractional Laser | Sciton Aesthetic & Medical Lasers

Halo™ – Hybrid Fractional Laser

Halo™, the world’s first Hybrid Fractional Laser (HFL), is revolutionizing resurfacing. Halo delivers non-ablative and ablative wavelengths to the same microscopic treatment zone, giving patients results they love without the discomfort or downtime they expect. Product Overview Halo, the world’s first hybrid fractional laser, applies tunable non-ablative (1470nm) and ablative (2940nm) wavelengths to the same microscopic treatment zone to maximize results and reduce downtime. Sciton’s new technology produces targeted, reproducible, effective results that improve the appearance of numerous skin conditions. Intelligent energy delivery, combined with Dynamic Thermal Optimization, ensures precise, even, safe treatments. Halo owners love achieving maximum return on their investment while exceeding their patients’ expectations. Easy to use and virtually painless, Halo sets the standard for the future of laser resurfacing by providing a safe and powerful long-term hybrid solution. As part of the multifaceted, expandable JOULE platform, Halo provides the practitioner with a dynamic and essential component of their aesthetic toolbox. Highlights Long term sun exposure, active lifestyle and the wear and tear of everyday living results in visible signs of skin aging, including wrinkles, discoloration, scars and laxity. A fractional treatment, whether ablative or coagulative, allows the epidermis to heal quickly as long as the dermis remains intact. Ablative fractional resurfacing

View this product at sciton.com